# EPCLUSA
> **NDA208341** · New Drug Application · Sponsor: GILEAD SCIENCES INC · Approved 2016-06-28
## Drug
- **FDA Application Number:** NDA208341
- **Application type:** New Drug Application
- **Brand name:** EPCLUSA
- **Generic name:** VELPATASVIR AND SOFOSBUVIR
- **Active ingredients:** SOFOSBUVIR; VELPATASVIR
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** GILEAD SCIENCES INC
- **Manufacturer:** Gilead Sciences, Inc.
- **First approval:** 2016-06-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208341)
---
*MORVS · CC0 1.0*